While reproductive events, including the menstrual cycle, hormonal contraceptive use, and the perinatal period, have long been associated with mental health risks, it remains unclear whether there is a single underlying reproductive psychiatric susceptibility associated with all of these, or if they represent distinct pathophysiological categories. Larsen et al. now provide the most reliable evidence to date for the former of these possibilities. This group analyzed all women in Denmark born after 1978 who delivered a child by 2017. They determined whether the onset of a depressive episode within 6 months of starting hormonal contraception was associated with an increased likelihood of a depressive episode within 6 months postpartum. They found evidence for a moderately strong association, with women who had prior contraceptive-associated depression at 1.42x higher odds for a postpartum depressive episode. This paper is particularly useful in that it allows for the first time an estimate of the relative prevalences of hormonally-associated versus non-hormonally associated depressive episodes. It has been hypothesized for some time that the hormonally-associated represent a subset of all perinatal depressive episodes, but solid numbers on the size of this subset have been lacking. Information from Larsen et al.'s Table 2 suggests that women with a psychiatric vulnerability to hormonal contraception may constitute about 3% of the population but account for about 24% of all women with non-perinatal depressive episodes, and furthermore that about 30% of all perinatal depressive episodes occurred in women with such a hormonally responsive psychiatric diathesis. Furthermore, Larsen et al. also confirm existing risk factors for perinatal depressive episodes, including personal and family psychiatric history, young parenthood, and low level of education, and allow a comparison of the relative risk weights conferred by each of these in comparison to the risk conferred by hormonal susceptibility. This information will be extremely helpful for researchers attempting to untangle the distinct pathophysiological pathways contributing to reproductive episodes of depression. It may also be helpful clinically for both clinicians and patients to gauge personal risk for postpartum depression.